¹Ì±¹ÀÇ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Áø´Ü ¹æ¹ýº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
U.S. Exocrine Pancreatic Insufficiency Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Method (Laboratory Tests, Imaging Tests), By End-use (Hospitals, Clinics, Diagnostic Laboratories), And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1511820
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 85 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,194,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,325,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View ResearchÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 23¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.04% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃéÀå Áúȯ ¹ßº´·ü Áõ°¡, ±â¼ú ¹ßÀü, À¯¸®ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê ¹× ÀÚ±Ý Áö¿ø µî ¿©·¯ °¡Áö ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾÷°èÀÇ ÁÖ¿ä ¹Ì·¡ Æ®·»µå´Â ±â°è ÇнÀ ¾Ë°í¸®Áò ¹× ÀΰøÁö´É(AI)°ú Áø´Ü µµ±¸ÀÇ ÅëÇÕÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, gastroenterology-AI Ç÷§Æû°ú °°Àº AI ±â¹Ý ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀº CT ½ºÄµ ¹× MRIÀÇ ÀÇ·á ¿µ»ó µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ÀÇ·á Àü¹®°¡°¡ ÃéÀå ±â´É ºÎÀüÀÇ Â¡Èĸ¦ º¸´Ù Á¤È®Çϰí È¿À²ÀûÀ¸·Î ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú µ¿ÇâÀº ÇâÈÄ Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í ÇØ¼® ¿À·ù¸¦ ÁÙÀ̸ç ȯÀÚ °á°ú¸¦ °³¼±ÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È Á¦Ç° ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ °í¼öÀ², °í½Å·Ú¼º Áø´Ü Àåºñ ¹× ¼Ò¸ðǰ °³¼±¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¿ä±¸°¡ ±× ¾î´À ¶§º¸´Ù ³ô¾ÆÁö°í ÀÖÀ¸¸ç, CT ½ºÄµ ¹× MRIÀÇ AI¿Í °°Àº »õ·Î¿î ½Ã´ëÀÇ ±â¼úÀº ±âÁ¸ Á¦Ç°ÀÇ ÆÇ¸Å¸¦ ¹æÇØÇÏ°í ½ÃÀå¿¡ »õ·Î¿î ¿¬±¸ °³¹ß ±âȸ¸¦ ¿­¾îÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¡°Ý, ȣȯ¼º, ¾ÈÀü¼º, °á°ú Á¦°ø ½Ã°£Àº »õ·Î¿î EPI °Ë»ç ±â¼úÀ» ±âÁ¸ EPI °Ë»ç ±â¼ú°ú Â÷º°È­ÇÏ´Â ÁÖ¿ä ¿äÀÎÀ̸ç, À̸¦ ÅëÇØ °æÀï ¿ìÀ§¸¦ È®º¸Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ALPCO Diagnostics´Â ´ëº¯ ³» ÃéÀå ¿¤¶ó½ºÅ¸Á¦(PE) È­Çй߱¤ ELISA ¹× CLIA °Ë»ç¸¦ Æ÷ÇÔÇÏ¿© ´ëº¯ ³» ÃéÀå ¿¤¶ó½ºÅ¸Á¦(PE)¸¦ ½Å¼ÓÇϰí Á¤È®ÇÏ°Ô °ËÃâÇϵµ·Ï ¼³°èµÈ ÃÖ÷´Ü °Ë»ç¹ýÀ» ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ºÐ¼®¹ýÀº ÀÇ·á Àü¹®°¡¿¡°Ô EPI¸¦ Áø´ÜÇÒ ¼ö ÀÖ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ» Á¦°øÇÏ¿© ½Å¼ÓÇÑ °³ÀÔ°ú ȯÀÚ ¿¹ÈÄ °³¼±À» ÃËÁøÇÕ´Ï´Ù. ±×·¯³ª °¢ ¾÷üµéÀº ´õ ³ôÀº È¿´É°ú ´õ Àú·ÅÇÑ ºñ¿ëÀ¸·Î ÀÌ¿ëÇÒ ¼ö ÀÖ´Â »õ·Î¿î Á¦Ç° °³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå : Áø´Ü ¹æ¹ýº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ ÃéÀå ¿ÜºÐºñ ±â´É ºÎÀü Áø´Ü ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Exocrine Pancreatic Insufficiency Diagnostics Market Growth & Trends:

The U.S. exocrine pancreatic insufficiency diagnostics market size is expected to reach USD 2.39 billion by 2030, growing at a CAGR of 7.04% from 2024 to 2030, according to a new report by Grand View Research, Inc. Several factors are driving market growth, including increasing incidence of pancreatic diseases, technological advancements, and favorable government initiatives & funding. A key future trend in the industry is the integration of machine learning algorithms and Artificial Intelligence (AI) with diagnostic tools. For instance, AI-based software platforms like the gastroenterology-AI platform analyze medical imaging data from CT scans or MRIs to assist healthcare professionals in identifying signs of pancreatic insufficiency more accurately and efficiently. This technological trend is expected to enhance diagnostic accuracy, reduce interpretation errors, and improve patient outcomes in the future, thereby driving the demand for products over the forecast period.

As the market becomes increasingly competitive, consumer needs are at an all-time high for improved diagnostic instruments and consumables in terms of high yield & robust outcomes. New-age technologies, such as AI in CT scans and MRIs, are expected to impede the sales of older products, opening new R&D opportunities in the market. Price, compatibility, safety, and time taken to provide results are major factors differentiating new EPI testing technologies from existing ones, thereby gaining a competitive edge over them. For instance, ALPCO Diagnostics introduces state-of-the-art assays, including the Pancreatic Elastase (PE) Chemiluminescence ELISA and CLIA tests, designed to detect pancreatic elastase rapidly & accurately in the stool. These advanced assays offer healthcare professionals a reliable means of diagnosing EPI, facilitating prompt intervention and improved patient outcomes. However, companies are focusing on developing newer products with higher efficacy made available at lower costs.

U.S. Exocrine Pancreatic Insufficiency Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Exocrine Pancreatic Insufficiency Diagnostics Market Variables, Trends & Scope

Chapter 4. U.S. Exocrine Pancreatic Insufficiency Diagnostics Market: Diagnostic Method Estimates & Trend Analysis

Chapter 5. U.S. Exocrine Pancreatic Insufficiency Diagnostics Market: End-use Estimates & Trend Analysis

Chapter 6. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â